D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 54 Citations 20,442 211 World Ranking 2891 National Ranking 130

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Her primary areas of investigation include Immunology, Internal medicine, Acquired immunodeficiency syndrome, Immunopathology and Viral load. Her work deals with themes such as Neutropenia and Combination therapy, which intersect with Immunology. The various areas that Jennifer F Hoy examines in her Internal medicine study include Lipodystrophy, Endocrinology, Surgery, Lipoatrophy and Stavudine.

Her work on Sida as part of general Acquired immunodeficiency syndrome research is frequently linked to Effects of sleep deprivation on cognitive performance, bridging the gap between disciplines. The concepts of her Immunopathology study are interwoven with issues in Viral disease and Immune system. Her studies in Viral load integrate themes in fields like Dementia, Pre-exposure prophylaxis and Risk factor.

Her most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)
  • CD4+ count-guided interruption of antiretroviral treatment. (1814 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Virology. Her Internal medicine study incorporates themes from Gastroenterology and Surgery. Her Immunology study frequently draws connections to adjacent fields such as Disease.

Her Disease research integrates issues from Pathogenesis and Intensive care medicine. Her biological study deals with issues like Cohort, which deal with fields such as Retrospective cohort study. Her Viral load research includes elements of Men who have sex with men and Antiretroviral therapy.

She most often published in these fields:

  • Internal medicine (52.73%)
  • Immunology (52.73%)
  • Acquired immunodeficiency syndrome (34.08%)

What were the highlights of her more recent work (between 2014-2021)?

  • Internal medicine (52.73%)
  • Immunology (52.73%)
  • Viral load (21.86%)

In recent papers she was focusing on the following fields of study:

Jennifer F Hoy mainly investigates Internal medicine, Immunology, Viral load, Men who have sex with men and Acquired immunodeficiency syndrome. Her work investigates the relationship between Internal medicine and topics such as Gastroenterology that intersect with problems in Coronary artery disease. She interconnects Dyslipidemia, Disease, Pharmacotherapy, Post-exposure prophylaxis and Prospective cohort study in the investigation of issues within Immunology.

Her study in Viral load is interdisciplinary in nature, drawing from both Treatment as prevention, Antiretroviral therapy and Health care. Her Men who have sex with men research incorporates elements of Cohort study, Reproductive health, Anal cancer, Family medicine and Gynecology. She works mostly in the field of Acquired immunodeficiency syndrome, limiting it down to concerns involving Cohort and, occasionally, Epidemiology and Transmission.

Between 2014 and 2021, her most popular works were:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel (414 citations)
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel (310 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Jennifer F Hoy mainly focuses on Internal medicine, Antiretroviral therapy, Pre-exposure prophylaxis, Viral load and Men who have sex with men. Her research investigates the link between Internal medicine and topics such as Surgery that cross with problems in Art initiation, Clinical trial and Efavirenz. Her Pre-exposure prophylaxis research is multidisciplinary, relying on both Integrase inhibitor, Incidence and Intensive care medicine.

Her studies examine the connections between Incidence and genetics, as well as such issues in Acquired immunodeficiency syndrome, with regards to Logistic regression, T cell, Circulating MicroRNA, Case-control study and microRNA. Viral load is a subfield of Immunology that Jennifer F Hoy studies. Many of her studies involve connections with topics such as Population study and Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

4699 Citations

CD4+ count-guided interruption of antiretroviral treatment.

Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin.
The New England Journal of Medicine (2006)

2887 Citations

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)

2374 Citations

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio.
JAMA (2016)

697 Citations

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy.
JAMA (2018)

604 Citations

Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.

S M Crowe;J B Carlin;K I Stewart;C R Lucas.
Journal of Acquired Immune Deficiency Syndromes (1991)

501 Citations

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim.
PLOS Pathogens (2014)

469 Citations

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Andrew Carr;Cassy Workman;Don E. Smith;Jennifer Hoy.
JAMA (2002)

394 Citations

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Allison Martin;Don E Smith;Andrew Carr;Clare Ringland.
AIDS (2004)

378 Citations

New spectrum of fungal infections in patients with cancer.

Elias Anaissie;Gerald P. Bodey;Hagop M Kantarjian;Jae Ro.
Clinical Infectious Diseases (1989)

343 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jennifer F Hoy

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 179

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 152

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 117

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 112

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 106

Matthew Law

Matthew Law

University of New South Wales

Publications: 92

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 85

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 83

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 79

Caroline Sabin

Caroline Sabin

University College London

Publications: 78

Dominique Costagliola

Dominique Costagliola

Sorbonne University

Publications: 77

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 69

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 67

Andrew Carr

Andrew Carr

University of Oxford

Publications: 66

Amy C. Justice

Amy C. Justice

Yale University

Publications: 66

James D. Neaton

James D. Neaton

University of Minnesota

Publications: 62

Trending Scientists

Katia Obraczka

Katia Obraczka

University of California, Santa Cruz

Shiliang Sun

Shiliang Sun

East China Normal University

Mausam

Mausam

Indian Institute of Technology Delhi

Yu-Bo Sheng

Yu-Bo Sheng

Nanjing University of Posts and Telecommunications

Franklin M. Orr

Franklin M. Orr

Stanford University

Shusheng Zhang

Shusheng Zhang

Qingdao University of Science and Technology

Philippe Maître

Philippe Maître

University of Paris-Saclay

Neil Spencer

Neil Spencer

University of Birmingham

Jin Zhu

Jin Zhu

Chinese Academy of Sciences

Zhiguo Liu

Zhiguo Liu

Nanjing University

Constantino Mpodozis

Constantino Mpodozis

University of Chile

Hreday N. Sapru

Hreday N. Sapru

Rutgers, The State University of New Jersey

Michele Tinazzi

Michele Tinazzi

University of Verona

George B. Stefano

George B. Stefano

Charles University

William V. Giannobile

William V. Giannobile

Harvard University

Cédric Lemogne

Cédric Lemogne

Université Paris Cité

Something went wrong. Please try again later.